Two weight-loss drugmakers in legal battle over which is most effective in helping users shed pounds
Novo Nordisk claims Eli Lilly compared peak doses of Zepbound against outdated, lower doses of Wegovy to advertise a 50-pound weight loss versus 33 pounds